The presence of TERT mutation is a prognostic and predictive biomarker in patients with cancer such as the central nervous system, bladder, thyroid, skin, etc., associated with tumor recurrence and survival.
With its features of detection limit as low as 5% copies/rxn, the PNAClamp™ TERT Mutation Detection Kit is the qualitative diagnostic test kit which is able to detect 2 different types of TERT promoter mutations of formalin-fixed paraffin-embedded (FFPE) tissue, fresh tissues and biopsy tissues using peptide nucleic acid (PNA)-mediated real-time PCR clamping technology.
FEATURES
Detection of 2 TERT promoter mutations
High sensitivity, specificity and reproducibility
Short running time
Simple workflow
Easy result reading by automatic analyzing program